LungLife AI (LSE:LLAI) Interest Expense : £-0.03 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. LungLife AI's interest expense for the six months ended in Dec. 2023 was £ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.03 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. LungLife AI's Operating Income for the six months ended in Dec. 2023 was £ -2.27 Mil. LungLife AI's Interest Expense for the six months ended in Dec. 2023 was £ -0.02 Mil. LungLife AI did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

LungLife AI Interest Expense Historical Data

The historical data trend for LungLife AI's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Interest Expense Chart

LungLife AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.43

-0.58

-0.31

-0.04

-0.03

LungLife AI Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial					-0.08	-0.02	-0.02	-0.02	-0.02

LungLife AI Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.03 Mil.

LungLife AI (LSE:LLAI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

LungLife AI's Interest Expense for the six months ended in Dec. 2023 was £-0.02 Mil. Its Operating Income for the six months ended in Dec. 2023 was £-2.27 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was £0.09 Mil.

LungLife AI's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

LungLife AI did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

LungLife AI (LSE:LLAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320

Website

https://www.lunglifeai.com

LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI (LSE:LLAI) Headlines

No Headlines